Consultant Vitreo-Retina and Uvea Services, Retina Speciality Hospital, Indore, India.
Director and Head of Retina Department, Retina Speciality Hospital, Indore, India.
Ocul Immunol Inflamm. 2023 Jan;31(1):127-133. doi: 10.1080/09273948.2021.1993271. Epub 2021 Nov 16.
To describe endogenous endophthalmitis in the setting of Covid-19 pneumonia post recovery.
Retrospective review of five patients of endogenous endophthalmitis following Covid-19 disease done.
All five cases had received systemic corticosteroid for a mean duration of 7 days during severe Covid-19 treatment. Decrease vision was presenting symptom between 1 and 31 days following Covid-19 recovery. All patients had presumed fungal endogenous endophthalmitis based on clinical profile. Four out of five patients subjected to pars plana vitrectomy had microbiologically proven aspergillus species endogenous endophthalmitis on vitreous fluid assessment; two cases each of aspergillus niger and aspergillus fumigates. Four eyes underwent pars plana vitrectomy with silicone oil injection had shown satisfactory anatomical outcome with control of the infection; however, no significant visual gain achieved.
We reported five cases of aspergillus endogenous endophthalmitis in Covid-19 recovered patients to document the likely presentation of this rising entity and avoid misdiagnosis.
描述新冠肺炎康复后发生的内源性眼内炎。
回顾性分析了 5 例新冠肺炎后发生的内源性眼内炎患者。
所有 5 例患者在新冠肺炎重症治疗期间均接受了平均 7 天的全身皮质类固醇治疗。在新冠肺炎康复后 1 至 31 天出现视力下降症状。所有患者均根据临床特征推测为真菌性内源性眼内炎。5 例患者中有 4 例接受了经睫状体平坦部玻璃体切除术,玻璃体液评估显示为曲霉菌属内源性眼内炎,其中曲霉菌属黑曲霉和烟曲霉各 2 例。4 只眼行经睫状体平坦部玻璃体切除术联合硅油注入术,感染得到控制,解剖学结果满意;然而,并未获得明显的视力提高。
我们报告了 5 例新冠肺炎康复患者的曲霉菌属内源性眼内炎病例,以记录这一新兴疾病实体的可能表现,避免误诊。